Skip to main navigation menu Skip to main content Skip to site footer
DOI:
https://doi.org/10.57187/5052

Original article

Vol. 156 No. 6 (2026)

New evidence of stagnation in mortality among young adults in Switzerland: a population-based study

Cite this as:
Swiss Med Wkly. 2026;156:5052
Published
26.06.2026

Summary

AIMS: To examine all-cause and cause-specific mortality by age group in Switzerland during and after the COVID-19 pandemic, in order to determine whether pre-pandemic trends recovered in 2023–24.

METHODS: Standardised mortality rates since COVID-19 were compared with those expected by continuing trends estimated over the pre-pandemic years 2000–19 by log-linear Poisson models, resulting in estimates of all-age and age-specific excess death and mortality for 2020–24. Mortality trends for the leading causes of death were analysed by age group using Joinpoint regression models.

RESULTS: In 2024, all-cause mortality in Switzerland showed a complete return to pre-pandemic trends. However, marked differences between age groups were observed. While mortality among people aged 85 and over was significantly lower than trend in 2024 (–5.4% for men and –3.5% for women), people aged 65 to 84 were still struggling to recover the pre-pandemic trend this year (+4.2% for men and +3.5% for women). Mortality in the 15–44 age group began to stagnate a few years before the pandemic and remained significantly above trend in recent years, with excess mortality being systematically outside the 95% prediction intervals, reaching +33.6% for men and +20.4% for women in 2024. At the same time, accidents and suicides, among the leading causes of death in this age group, appear to have stopped declining, with a stabilisation in the suicide trend since 2014 among men (p = 0.005) and 2013 among women (p = 0.001), and in the accident trend since 2019 among men (p = 0.031). A slowdown in the decline of cardiovascular and respiratory mortality has been observed in the 65–84 age group.

CONCLUSIONS: The long-standing decline in mortality has stalled in recent years in Switzerland among young adults and, to a lesser extent, among young retirees, due to stagnation or slowdown of several major causes of death in these age groups. These phenomena, in addition to their importance for considering appropriate preventive interventions, also raise questions about the future of mortality and longevity in Switzerland and, more generally, in Western societies, and must be taken into account when developing realistic life expectancy and demographic scenarios. These are essential for decision-making in the areas of insurance, retirement planning and healthcare cost management.

References

  1. 1. Choi J, Ki M, Kwon HJ, Park B, Bae S, Oh CM, et al. Health Indicators Related to Disease, Death, and Reproduction. J Prev Med Public Health. 2019 Jan;52(1):14–20. 10.3961/jpmph.18.250
  2. 2. Beaney T, Clarke JM, Jain V, Golestaneh AK, Lyons G, Salman D, et al. Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide? J R Soc Med. 2020 Sep;113(9):329–34. 10.1177/0141076820956802
  3. 3 COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 (2022). Lancet 16: 399(10334):1513–1536. https://doi.org/10.1016/S0140-6736(21)02796-3
  4. 4. Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023 Jan;613(7942):130–7. 10.1038/s41586-022-05522-2
  5. 5. Aburto JM, Schöley J, Kashnitsky I, Zhang L, Rahal C, Missov TI, et al. Quantifying impacts of the COVID-19 pandemic through life-expectancy losses: a population-level study of 29 countries. Int J Epidemiol. 2022 Feb;51(1):63–74. 10.1093/ije/dyab207
  6. 6. Schöley J, Aburto JM, Kashnitsky I, Kniffka MS, Zhang L, Jaadla H, et al. Life expectancy changes since COVID-19. Nat Hum Behav. 2022 Dec;6(12):1649–59. 10.1038/s41562-022-01450-3
  7. 7. EuroMOMO. Internet : https://www.euromomo.eu/
  8. 8. eurostat. Mortality and life expectancy statistics. Internet: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Mortality_and_life_expectancy_statistics
  9. 9. Wrigley-Field E, Raquib RV, Berry KM, Morris KJ, Stokes AC. Mortality Trends Among Early Adults in the United States, 1999-2023. JAMA Netw Open. 2025 Jan;8(1):e2457538. 10.1001/jamanetworkopen.2024.57538
  10. 10. Pérez-Reche FJ. (2024). Age-specific all-cause mortality trends in the UK: Pre-pandemic increases and the complex impact of COVID-19, Public Health, 236, ISSN 0033-3506, https://doi.org/10.1016/j.puhe.2024.09.007
  11. 11. Locatelli I, Rousson V. A first analysis of excess mortality in Switzerland in 2020. PLoS One. 2021 Jun;16(6):e0253505. 10.1371/journal.pone.0253505
  12. 12. Locatelli I, Rousson V. Mortality in Switzerland in 2021. PLoS One. 2022 Sep;17(9):e0274295. 10.1371/journal.pone.0274295
  13. 13. Locatelli I, Rousson V. Two complementary approaches to estimate an excess of mortality: the case of Switzerland 2022. PLoS One. 2023 Aug;18(8):e0290160. 10.1371/ journal.pone.0290160 doi: https://doi.org/10.1371/journal.pone.0290160
  14. 14. Neison F. On a method recently proposed for conducting inquiries into the comparative sanatory condition of various districts [now the Royal Statistical Society]. J Stat Soc Lond. 1844;7(1):40–68. doi: https://doi.org/10.2307/2337745
  15. 15 Fleiss JL, Levin B, Cho PaikM (2003). Statistical methods for rates and proportions. Wiley Series in Probability and Statistics Eds
  16. 16. Grize L, Huss A, Thommen O, Schindler C, Braun-Fahrländer C. Heat wave 2003 and mortality in Switzerland. Swiss Med Wkly. 2005 Apr;135(13-14):200–5.
  17. 17. Vicedo-Cabrera AM, Ragettli MS, Schindler C, Röösli M. Excess mortality during the warm summer of 2015 in Switzerland. Swiss Med Wkly. 2016;146(4950):w14379. doi: https://doi.org/10.4414/smw.2016.14379
  18. 18. Ragettli MS, Flückiger B, Vienneau D, Domingo-Irigoyen S, Koschenz M, Röösli M. Vulnerability to heat-related mortality and the effect of prevention measures: a time-stratified case-crossover study in Switzerland. Swiss Med Wkly. 2024 Oct;154(10):3410. doi: https://doi.org/10.57187/s.3418
  19. 19. EDITORIAL. ICD-10: there’s a code for that. Lancet. 2015 Oct;386(10002):1420. doi: https://doi.org/10.1016/S0140-6736(15)00453-5
  20. 20. World Health Organization WHO. Geneva (1977). Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Vol. 1
  21. 21. Chammartin F, Probst-Hensch N, Utzinger J, Vounatsou P. Mortality atlas of the main causes of death in Switzerland, 2008-2012. Swiss Med Wkly. 2016 Feb;146(708):w14280. doi: https://doi.org/10.4414/smw.2016.14280
  22. 22. Sunghal T, Widmer K, Beloconi A, Dhaini S, Schwenkglenks M, Blohm C, et al. Mortality atlas of the main causes of death for the elderly population (≥75 years) in Switzerland during 2010–2020. Swiss Med Wkly. 2025;155(5):3433. doi: https://doi.org/10.57187/s.3433
  23. 23. Arslani K, Tontsch J, Todorov A, Gysi B, Kaufmann M, Kaufmann F, et al.; Swiss Society of Intensive Care Medicine. Temporal trends in mortality and provision of intensive care in younger women and men with acute myocardial infarction or stroke. Crit Care. 2023 Jan;27(1):14. doi: https://doi.org/10.1186/s13054-022-04299-0
  24. 24. Frisone D, Sandoval J, Friedlaender A, Olivier T, Addeo A. Trends in incidence and mortality of lung cancer in Switzerland: possible explanations and open questions. Cancer Epidemiol. 2022 Oct;80:102232. doi: https://doi.org/10.1016/j.canep.2022.102232
  25. 25. Wanner M, Matthes KL, Karavasiloglou N, Limam M, Korol D, Rohrmann S. 37-year incidence and mortality time trends of common cancer types by sex, age, and stage in the canton of Zurich. Swiss Med Wkly. 2020 Dec;150(5153):w20388. doi: https://doi.org/10.4414/smw.2020.20388
  26. 26. Savidan A, Junker C, Cerny T, Ess S. Premature deaths in Switzerland from 1995-2006: causes and trends. Swiss Med Wkly. 2010 Aug;140(3334):w13077. doi: https://doi.org/10.4414/smw.2010.13077
  27. 27. Human Mortality Database. Internet: https://www.mortality.org/
  28. 28. Swiss Federal Statistical Office. Specific causes of death. Internet: https://www.bfs.admin.ch/bfs/en/home/statistics/health/state-health/mortality-causes-death/specific.html
  29. 29. Revision of the European Standard Population - Report of Eurostat's task force - 2013 edition. doi:10.2785/11470
  30. 30. Muggeo VM. Estimating regression models with unknown break-points. Stat Med. 2003 Oct;22(19):3055–71. doi: https://doi.org/10.1002/sim.1545
  31. 31. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2024.
  32. 32. Muggeo VM. Segmented: An R Package to Fit Regression Models with Broken-Line Relationships. R News. 2008;8:20–5.
  33. 33. Israel RA, Rosenberg HM, Curtin LR. Analytical potential for multiple cause-of-death data. Am J Epidemiol. 1986 Aug;124(2):161–79. doi: https://doi.org/10.1093/oxfordjournals.aje.a114375
  34. 34. Lindahl BI, Johansson LA. Multiple cause-of-death data as a tool for detecting artificial trends in the underlying cause statistics: a methodological study. Scand J Soc Med. 1994 Jun;22(2):145–58. doi: https://doi.org/10.1177/140349489402200211
  35. 35. Durán N D, Kaufman JS, Chiolero A, Carmeli C. Multiple causes of death data to track trends of mortality from chronic diseases: insights from the COVID-19 pandemic in Switzerland. Ann Epidemiol. 2026 Jan;113:23–9. doi: https://doi.org/10.1016/j.annepidem.2025.12.002
  36. 36. Ferenci T. (2023). Comparing methods to predict baseline mortality for excess mortality calculations–unravelling ‘the German puzzle’ and its implications for spline-regression. MedRxiv https://doi.org/10.1101/2022.07.18.22277746
  37. 37. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009 Oct;374(9696):1196–208. 10.1016/S0140-6736(09)61460-4
  38. 38. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002 May;296(5570):1029–31. 10.1126/science.1069675
  39. 39. Vallin J, Meslé F. The segmented trend line of highest life expectancies. Popul Dev Rev. 2009;35(1):35. doi: https://doi.org/10.1111/j.1728-4457.2009.00264.x
  40. 40. Vaupel JW. Biodemography of human ageing. Nature. 2010 Mar;464(7288):536–42. 10.1038/nature08984
  41. 41. Beltrán-Sánchez H, Preston SH, Canudas-Romo V. An integrated approach to cause-of-death analysis: cause-deleted life tables and decompositions of life expectancy. Demogr Res. 2008 Jul;19:1323–50. 10.4054/DemRes.2008.19.35